AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹60.02 | ₹54.16 | ₹32.90 | ₹45.20 | ₹91.05 |
What is the latest Earnings Per Share (EPS) of AUROBINDO PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹60.02 |
| Mar2025 | ₹54.16 |
| Mar2024 | ₹32.90 |
| Mar2023 | ₹45.20 |
| Mar2022 | ₹91.05 |
How is Earnings Per Share (EPS) of AUROBINDO PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹60.02 | 10.82 | |
| Mar2025 | ₹54.16 | 64.62 | |
| Mar2024 | ₹32.90 | -27.21 | |
| Mar2023 | ₹45.20 | -50.36 | |
| Mar2022 | ₹91.05 | - | |
Compare Earnings Per Share (EPS) of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹96,839.8 Cr | 0.8% | 0.8% | 53.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.8% |
0.8% |
53.8% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses